These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 29391761)

  • 1. Autoimmune liver disease-related autoantibodies in patients with biliary atresia.
    Pang SY; Dai YM; Zhang RZ; Chen YH; Peng XF; Fu J; Chen ZR; Liu YF; Yang LY; Wen Z; Yu JK; Liu HY
    World J Gastroenterol; 2018 Jan; 24(3):387-396. PubMed ID: 29391761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
    Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
    J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antilactoferrin antibodies in autoimmune liver disease.
    Muratori L; Muratori P; Zauli D; Grassi A; Pappas G; Rodrigo L; Cassani F; Lenzi M; Bianchi FB
    Clin Exp Immunol; 2001 Jun; 124(3):470-3. PubMed ID: 11472410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases.
    Roozendaal C; de Jong MA; van den Berg AP; van Wijk RT; Limburg PC; Kallenberg CG
    J Hepatol; 2000 May; 32(5):734-41. PubMed ID: 10845659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune liver disease serology in acute hepatitis E virus infection.
    Terziroli Beretta-Piccoli B; Ripellino P; Gobbi C; Cerny A; Baserga A; Di Bartolomeo C; Bihl F; Deleonardi G; Melidona L; Grondona AG; Mieli-Vergani G; Vergani D; Muratori L;
    J Autoimmun; 2018 Nov; 94():1-6. PubMed ID: 30336842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatic Disease Autoantibodies in Autoimmune Liver Diseases.
    Utiyama SR; Zenatti KB; Nóbrega HA; Soares JZ; Skare TL; Matsubara C; Muzzilo DA; Nisihara RM
    Immunol Invest; 2016 Aug; 45(6):566-73. PubMed ID: 27409579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
    Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
    J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.
    Li BA; Liu J; Hou J; Tang J; Zhang J; Xu J; Song YJ; Liu AX; Zhao J; Guo JX; Chen L; Wang H; Yang LH; Lu J; Mao YL
    World J Gastroenterol; 2015 Jan; 21(1):283-91. PubMed ID: 25574103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and prognostic effects of cholangitis after Kasai procedure in biliary atresia patients: A retrospective clinical study.
    Liu J; Dong R; Chen G; Dong K; Zheng S
    J Pediatr Surg; 2019 Dec; 54(12):2559-2564. PubMed ID: 31668401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of the Contribution of Autoantibodies to Clinical Diagnosis in Liver Pathologies and the Identification of Accompanying Autoimmune Diseases].
    Duran A; Çetin Duran A; Taşkıran İ
    Mikrobiyol Bul; 2022 Jan; 56(1):81-94. PubMed ID: 35088962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis.
    Sobajima J; Ozaki S; Uesugi H; Osakada F; Inoue M; Fukuda Y; Shirakawa H; Yoshida M; Rokuhara A; Imai H; Kiyosawa K; Nakao K
    Gut; 1999 Jun; 44(6):867-73. PubMed ID: 10323891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serology in autoimmune hepatitis: A clinical-practice approach.
    Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
    Eur J Intern Med; 2018 Feb; 48():35-43. PubMed ID: 29056396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C.
    Ohira H; Tojo J; Shinzawa J; Suzuki T; Miyata M; Nishimaki T; Kasukawa R
    Fukushima J Med Sci; 1998 Dec; 44(2):83-92. PubMed ID: 10091380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
    Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
    Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).
    Stinton LM; Bentow C; Mahler M; Norman GL; Eksteen B; Mason AL; Kaplan GG; Lindkvist B; Hirschfield GM; Milkiewicz P; Cheung A; Janssen HL; Fritzler MJ
    PLoS One; 2014; 9(11):e112877. PubMed ID: 25397578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.
    Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
    J Autoimmun; 2018 Dec; 95():144-158. PubMed ID: 30366656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
    Papp M; Sipeki N; Vitalis Z; Tornai T; Altorjay I; Tornai I; Udvardy M; Fechner K; Jacobsen S; Teegen B; Sumegi A; Veres G; Lakatos PL; Kappelmayer J; Antal-Szalmas P
    J Hepatol; 2013 Sep; 59(3):457-66. PubMed ID: 23639483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.